Treatment of Bilateral Endogenous Aspergillus Endophthalmitis with Multiple Intravitreal Voriconazole Injections with

Inas F Aboobakar1, Sally S Ong1, Akosua Nti1

  • 1Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA.

Insights

Endogenous Aspergillus endophthalmitis is aggressive. This case study shows multiple intravitreal voriconazole injections effectively treated bilateral Aspergillus endophthalmitis, improving vision.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Mycology

Background:

  • Endogenous endophthalmitis caused by Aspergillus species presents a significant challenge due to its aggressive nature and potential for severe vision loss.
  • Intravitreal amphotericin B has been a historical treatment, but outcomes are variable and toxicity is a concern.

Observation:

  • A case of bilateral endogenous Aspergillus endophthalmitis is presented.
  • The patient received multiple intravitreal injections of voriconazole: 8 in the right eye and 11 in the left eye.

Findings:

  • Treatment with a high number of intravitreal voriconazole injections resulted in good final visual acuity in both eyes (20/50 OD, 20/40 OS).
  • This suggests intravitreal voriconazole can be a safe and effective treatment for severe Aspergillus endophthalmitis, even with repeated administration.

Implications:

  • These findings support the expanded use of intravitreal voriconazole for managing aggressive endogenous Aspergillus endophthalmitis.
  • Further research into optimal dosing and duration of intravitreal voriconazole therapy is warranted.